Home / Clinical trials / Teriparatide
Are there clinical trials for Teriparatide?
Teriparatide has 182 registered clinical trials, including 114 completed interventional studies and trials reaching Phase 4. Its use in humans is supported by established registered clinical evidence.
Trial breakdown
By phase
| Phase 4 | 48 |
| Phase 2 | 46 |
| Phase 3 | 34 |
| Phase 1 | 18 |
| Not applicable | 17 |
By status
| Completed | 125 |
| Unknown status | 23 |
| Terminated | 10 |
| Active, not recruiting | 6 |
| Withdrawn | 6 |
| Recruiting | 6 |
| Not yet recruiting | 3 |
| Enrolling by invitation | 2 |
| Suspended | 1 |
Active trials
- A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing RegimensPhase 2 · Recruiting · 200 participants · Shenzhen Salubris Pharmaceuticals Co., Ltd. · started 2026-04-30NCT07579936
- A Study of B-3E07 and Forsteo® in Healthy Adult Female ParticipantsPhase 1 · Recruiting · 48 participants · Syneos Health · started 2026-04-10NCT07497503
- To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of FracturePhase 3 · Not yet recruiting · 282 participants · Qilu Pharmaceutical Co., Ltd. · started 2025-06NCT06898060
- Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal OsteoporosisNot applicable · Not yet recruiting · 28 participants · Peking University Third Hospital · started 2025-05-01NCT06951776
- Combined Anabolic TherapyPhase 4 · Recruiting · 50 participants · Massachusetts General Hospital · started 2025-02-03NCT06558188
- Post-surgical Outcomes With Anabolic Agent Use in High-risk Ankle Fractures: A Pilot RCTPhase 1 / Phase 2 · Not yet recruiting · 80 participants · University of Calgary · started 2025-01-01NCT06303284
- Precision Medicine Approach for Osteoporosis - Follow Up StudyPhase 4 · Enrolling by invitation · 40 participants · Paul F Netzel · started 2024-02-01NCT06264609
- Sequential Therapies After Osteoanabolic TreatmentRecruiting · 150 participants · 424 General Military Hospital · started 2023-11-25NCT06164795
Most recent registered trials
- A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing RegimensPhase 2 · Recruiting · 200 participants · Shenzhen Salubris Pharmaceuticals Co., Ltd. · started 2026-04-30NCT07579936
- A Study of B-3E07 and Forsteo® in Healthy Adult Female ParticipantsPhase 1 · Recruiting · 48 participants · Syneos Health · started 2026-04-10NCT07497503
- Bone Turnover Markers and Treatment Efficacy in Postmenopausal OsteoporosisNot applicable · Completed · 40 participants · Khyber Medical University Peshawar · started 2025-10-01NCT07242612
- To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of FracturePhase 3 · Not yet recruiting · 282 participants · Qilu Pharmaceutical Co., Ltd. · started 2025-06NCT06898060
- Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal OsteoporosisNot applicable · Not yet recruiting · 28 participants · Peking University Third Hospital · started 2025-05-01NCT06951776
- Combined Anabolic TherapyPhase 4 · Recruiting · 50 participants · Massachusetts General Hospital · started 2025-02-03NCT06558188
- Post-surgical Outcomes With Anabolic Agent Use in High-risk Ankle Fractures: A Pilot RCTPhase 1 / Phase 2 · Not yet recruiting · 80 participants · University of Calgary · started 2025-01-01NCT06303284
- A Study of TeriQ Patch in Healthy Adult Female ParticipantsPhase 1 · Completed · 24 participants · QuadMedicine · started 2024-10-25NCT06644040
- Precision Medicine Approach for Osteoporosis - Follow Up StudyPhase 4 · Enrolling by invitation · 40 participants · Paul F Netzel · started 2024-02-01NCT06264609
- Sequential Therapies After Osteoanabolic TreatmentRecruiting · 150 participants · 424 General Military Hospital · started 2023-11-25NCT06164795
- Teriparatide on Maxillary Sinus Floor OsseointegrationPhase 4 · Unknown status · 42 participants · Universidad de Valparaiso · started 2023-08-23NCT06061354
- Study of the Key Techniques of Prevention and Treatment of Osteoporotic RefractureNot applicable · Recruiting · 2478 participants · Peking Union Medical College Hospital · started 2023-05-26NCT05866029
Frequently asked questions
Are there clinical trials for Teriparatide?
Teriparatide has 182 registered clinical trials, including 114 completed interventional studies and trials reaching Phase 4. Its use in humans is supported by established registered clinical evidence.
Does a registered trial mean the peptide works?
No. Registration means a study was formally listed before or during the research. It says nothing about the result. A completed trial can find no benefit, and many registered studies are never published.
What is the difference between a registered trial and published evidence?
Registration records that a study exists. Publication reports what it found. This page counts registrations, which is the more complete picture of research activity, but it is not a measure of proven effectiveness.
Why do phases matter?
Phase 1 tests safety in a small group. Phase 2 looks for early signs of effect. Phase 3 tests effectiveness against a comparator in a large group, and is what regulators normally require. Phase 4 studies happen after approval. A compound with only Phase 1 trials has not been shown to work.
Source: ClinicalTrials.gov API v2, U.S. National Library of Medicine. Studies where Teriparatide is registered as an intervention. Last updated 2026-09-23.